Canexia Health
Canexia Health (formerly Contextual Genomics) makes high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support. Our genomics-based oncology solutions are designed to advance cancer prevention, treatment, and monitoring. Founded and led by global experts in cancer genomics and bioinformatics, and with support from pharmaceutical and diagnostic partners, we are leading the shift towards precision oncology. Only a small percentage of cancer patients receive genetic biomarker testing that could match them with targeted treatments demonstrated to improve patient outcomes. At Canexia Health, we pair the latest advances in oncology with machine learning to provide cancer professionals with the insights needed to make targeted treatment decisions for their patients.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Clinical Services
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2012
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Expanding cancer treatment options
Only a small percentage of cancer patients receive genetic biomarker testing that could match them with targeted treatments demonstrated to improve patient outcomes. At Canexia Health, we pair the latest advances in oncology with machine learning to provide cancer professionals with the insights needed to make targeted treatment decisions for their patients.
Together, we’re making precision oncology more accessible.
Global leaders since 2012
Our expertise in genomics-based cancer diagnostics and bioinformatics runs deep, thanks to the strong foundation laid by our scientific and medical leaders, Drs. Samuel Aparicio, David Huntsman, and Sohrab Shah.
Our founders have earned international recognition for their work in cancer research. Collectively, they’ve published more than 400 peer-reviewed articles in the fields of cancer genomics, diagnosis, and bioinformatics, including in the New England Journal of Medicine, Science, Nature and Nature Genetics.